Form D · Biotechnology

CODEXIS, INC.

Redwood City, CA · CIK 0001200375

Offering snapshot reported Jun 20, 2019 · SEC filing

Reported sold
$50M
Offering amount: $50M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 20, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 20, 2019Initial$50,000,000No comparison1SEC filing
Oct 12, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Aug 1, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Nov 9, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Jun 9, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Nov 9, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-342362

Source: Form D, filed Jun 20, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Thomas Baruch Director
Pam Cheng Director
Byron Dorgan Director
Kathleen Glaub Director
Bernard Kelley Director
John Nicols Director, Executive
Gordon Sangster Executive
David Smith Director
Dennis Wolf Director
Patrick Yang Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
200 Penobscot Drive
Redwood City, CA, 94063